Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 4/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | ASAH1 | Q13510 | 2/20 | 0.78 |
| ▸ | TP53 | P04637 | 2/20 | 0.75 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.75 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.75 |
| ▸ | MAPT | P10636 | 1/20 | 0.75 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.75 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.75 |
| ▸ | ASAH2 | Q9NR71 | 2/20 | 0.71 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.70 |
| ▸ | PLA2G4A | P47712 | 4/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13863420 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL22973496 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL5527047 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL22911186 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL22973426 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL24032894 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL22973497 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL22910831 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL22910800 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL14032326 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121775140-A | Application of ceramide and synthesis regulator thereof in regulation of porcine epidemic diarrhea virus infection | 中国农业大学 | 2026-04-03 | — | — | CN | disclosed |
| US-12390490-B2 | Sphingolipid-based selenium compounds, methods for their preparation, and pharmaceutical uses thereof, including as antitumor agents | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT | 2025-08-19 | — | — | US | disclosed |
| CN-119654140-A | Lipid nanoparticles comprising long chain ceramides and compositions for apoptosis comprising the same | 禾大韩国有限公司 | 2025-03-18 | — | — | CN | disclosed |
| WO-2024210692-A1 | HIGHLY WATER-DISPERSIBLE COMPOSITION HAVING HIGH CERAMIDE CONTENT | 주식회사 무진메디 | 2024-10-10 | — | — | WO | disclosed |
| CN-117462461-A | Skin barrier repairing composition, and cosmetics and application thereof | 欧诗漫生物股份有限公司 | 2024-01-30 | — | — | CN | disclosed |
| US-20230392147-A1 | MAMMALIAN CELLS FOR PRODUCING A SECRETED PROTEIN | BOEHRINGER INGELHEIM INT (DE) | 2023-12-07 | — | — | US | disclosed |
| US-20230372207-A1 | CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN | KAO CORPORATION (JP) | 2023-11-23 | — | — | US | disclosed |
| US-20230372207-A1 | CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN | KAO CORPORATION (JP) | 2023-11-23 | — | — | US | disclosed |
| US-20230240948-A1 | METHOD FOR PRODUCING COATING | KAO CORPORATION (JP) | 2023-08-03 | — | — | US | disclosed |
| US-20230240948-A1 | METHOD FOR PRODUCING COATING | KAO CORPORATION (JP) | 2023-08-03 | — | — | US | disclosed |
| US-7511010-B2 | Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting Langerhans' cell migration | LABORATOIRES EXPANSCIENCE (FR) | 2009-03-31 | — | — | US | disclosed |
| US-20090081148-A1 | PROTECTION OF KERATINOUS FIBERS USING CERAMIDES AND/OR GLYCOCERAMIDES | L'OREAL S.A. | 2009-03-26 | — | — | US | disclosed |
| US-20090081148-A1 | PROTECTION OF KERATINOUS FIBERS USING CERAMIDES AND/OR GLYCOCERAMIDES | L'OREAL S.A. | 2009-03-26 | — | — | US | disclosed |
| US-20090047231-A1 | AQUEOUS HAIR COSMETIC COMPOSITION | KAO CORPORATION (JP) | 2009-02-19 | — | — | US | disclosed |
| US-20090047231-A1 | AQUEOUS HAIR COSMETIC COMPOSITION | KAO CORPORATION (JP) | 2009-02-19 | — | — | US | disclosed |
| US-20080299063-A1 | HAIR COSMETIC COMPOSITION | KAO CORPORATION (JP) | 2008-12-04 | — | — | US | disclosed |
| US-20080299063-A1 | HAIR COSMETIC COMPOSITION | KAO CORPORATION (JP) | 2008-12-04 | — | — | US | disclosed |
| US-20080221017-A1 | Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting langerhans cell migration | LABORATOIRES EXPANSCIENCE | 2008-09-11 | — | — | US | disclosed |
| US-20080221017-A1 | Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting langerhans cell migration | LABORATOIRES EXPANSCIENCE | 2008-09-11 | — | — | US | disclosed |
| EP-1468666-B1 | Hair shampoo composition | KAO CORP (JP) | 2008-06-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12390490-B2 | Sphingolipid-based selenium compounds, methods for their preparation, and pharmaceutical uses thereof, including as antitumor agents | SGMS1, SGMS2, SELENOI | CETP 1633/4885THRB 3639/4885MEN1 69/4885 |
| US-20080299063-A1 | HAIR COSMETIC COMPOSITION | H1-0, H1-3, H1-2 | CETP 1482/4885THRB 1149/4885MEN1 314/4885 |
| US-20230240948-A1 | METHOD FOR PRODUCING COATING | CUTA, KRT18, S100B | CETP 132/4885THRB 3756/4885MEN1 2776/4885 |
| US-20090081148-A1 | PROTECTION OF KERATINOUS FIBERS USING CERAMIDES AND/OR GLYCOCERAMIDES | KRT18, CERT1, CERS2 | CETP 166/4885THRB 4842/4885MEN1 3014/4885 |
| US-20090047231-A1 | AQUEOUS HAIR COSMETIC COMPOSITION | POLR1C, CUTA, POLH | CETP 540/4885THRB 173/4885MEN1 1367/4885 |
| US-20230372207-A1 | CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN | CERT1, CERS2, SGMS2 | CETP 42/4885THRB 4468/4885MEN1 3467/4885 |
| US-20080221017-A1 | Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting langerhans cell migration | MMP1, MMP13, MMP2 | CETP 632/4885THRB 4422/4885MEN1 3549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.